Sign in

CIK 0000907654

  • Non-accelerated filer
  • Smaller reporting company

Oruka Therapeutics, Inc.

Sign in to watch
Ticker
ORKA
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
363855489
Phone
+1 650-606-7910
Business address
855 OAK GROVE AVE., SUITE 100, MENLO PARK, CA, 94025
Former names
ARCA biopharma, Inc., NUVELO INC, HYSEQ INC
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$21,431,111
in 18 filings, $21.0M under 10b5-1 plans

Net −$21,431,111. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Date Insider Transaction Shares Price Value Owned after
2013-09-17 ZABRISKIE JOHN L Director Grant or award · Stock Option (right to buy) +7,417 7,417
2013-09-17 Wheeler Patrick M Chief Financial Officer Grant or award +75,000 $1.38 $104K 75,556
2013-09-17 Wheeler Patrick M Chief Financial Officer Grant or award · Stock Option (right to buy) +81,856 81,856
2013-09-17 Woosley Raymond L. Director Grant or award · Stock Option (right to buy) +14,750 14,750
2013-09-17 Woosley Raymond L. Director Grant or award · Stock Option (right to buy) +3,463 3,463
2013-09-17 BRISTOW MICHAEL R Pres & CEO Grant or award +125,000 $1.38 $173K 249,778
2013-09-17 BRISTOW MICHAEL R Pres & CEO Grant or award · Stock Option (right to buy) +282,825 282,825
2013-09-17 Grais Linda S Director Grant or award · Stock Option (right to buy) +16,000 16,000
2013-09-17 Grais Linda S Director Grant or award · Stock Option (right to buy) +7,417 7,417
2013-09-17 CONWAY ROBERT E Director Grant or award · Stock Option (right to buy) +14,750 14,750
2013-09-17 CONWAY ROBERT E Director Grant or award · Stock Option (right to buy) +2,608 2,608
2013-09-17 Ozeroff Christopher David S.V.P., General Counsel Grant or award +75,000 $1.38 $104K 92,537
2013-09-17 Ozeroff Christopher David S.V.P., General Counsel Grant or award · Stock Option (right to buy) +42,642 42,642
2013-07-26 Grais Linda S Director Grant or award · Option to Purchase Common Stock (right to buy) +583 583
2013-07-26 ZABRISKIE JOHN L Director Grant or award · Option to Purchase Common Stock (right to buy) +583 583
2013-06-12 BRISTOW MICHAEL R President and CEO Conversion · Series A Convertible Preferred Stock −781 $160.00 $125K 0
2013-06-04 BRISTOW MICHAEL R President and CEO Grant or award · Series A Convertible Preferred Stock +781 $160.00 $125K 781
2013-06-04 BRISTOW MICHAEL R President and CEO Grant or award · Common Stock Warrants (right to buy) +39,050 39,050
2013-01-25 BRISTOW MICHAEL R President and CEO Purchase +1,069,290 $0.47 $500K 1,069,290
2013-01-25 BRISTOW MICHAEL R President and CEO Purchase · Common stock warrants (right to buy) +748,503 748,503

Page 26 of 41 · 802 trades